Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Subjects
In brief
The purpose of this study is to examine the effect of SKI-606 on rhythms of the heart (cardiac repolarization)
Key facts
- Study ID
- NCT00914121
- Run by
- Wyeth is now a wholly owned subsidiary of Pfizer
- People needed
- 60
- Starts
- 2009-06-01
- Expected to finish
- 2009-08-01
- Last updated by the study team
- 2009-09-02
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
Where it is running
- Study site — Tacoma, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.